@benelong: And only just over $2 million AUD for the patent. Deal of the century, I say.
Another point I will pitch in: the operative word was DURABLE.
"MLCs modified using this proprietary cell targeting technology, called ex vivo fucosylation, have successfully induced durable reversal of Type 1 diabetes in a preclinical study".
It wasn't a temporary reversal. It was sustained. It was durable.
It is awesome.
It is freaking holy bejeezsus awesome.
SI = The MAD Professor who can work deals as well as get patents, teach, research, make us rich and above all, reduce human suffering!
Type 1 diabetes ann., page-24
-
- There are more pages in this discussion • 20 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.01 |
Change
0.000(0.00%) |
Mkt cap ! $1.153B | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 18829 | $1.06 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 96.0¢ | 19342 | 2 |
View Market Depth
| Last trade - 10.00am 19/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |
Day chart unavailable